Patent Application for Microstructure Array Delivering Active Agents
Summary
The USPTO has published a patent application (US20260083948A1) for a microstructure array designed for delivering active agents through the skin. The application details a formulation comprising dissolving microstructures attached to a base, intended for transdermal drug delivery.
What changed
This document is a published patent application from the USPTO detailing a novel microstructure array for transdermal delivery of active agents. The application, filed under application number 19202874, describes a system with dissolving microstructures containing active agents in a biocompatible matrix, designed to penetrate the skin and release the agent. It also covers related formulations, preparation methods, and administration techniques.
While this is a patent application and not a regulatory rule, it signifies potential future product development in the pharmaceutical and medical device sectors. Companies involved in transdermal drug delivery, microneedle technology, or active agent formulations should be aware of this innovation as it may influence future product pipelines and intellectual property landscapes. No immediate compliance actions are required, but monitoring patent filings is crucial for competitive intelligence and R&D strategy.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
MICROSTRUCTURE ARRAY FOR DELIVERY OF ACTIVE AGENTS
Application US20260083948A1 Kind: A1 Mar 26, 2026
Inventors
Guohua CHEN, Sahitya Katikaneni, Esi Ghartey-Tagoe, Parminder Singh
Abstract
Provided herein is a microstructure array comprising a plurality of dissolving microstructures such as microprojections attached to a base. The plurality of microstructures comprise an active agent in a biocompatible and water-soluble matrix, where the water-soluble matrix preferably comprises a polysaccharide polymer and a sugar alcohol, and the base typically comprises a non-water soluble matrix. The plurality of microstructures, upon penetration of the subject's skin, undergo dissolution to deliver the active agent. Also provided are related microstructure formulations, in dried and liquid form, methods for preparing the above-described microstructure arrays, and methods for administering an active agent by application of a microstructure array as provided herein to a subject's skin, among other features.
CPC Classifications
A61M 37/0015 A61K 9/0021 A61K 39/00 A61K 47/34 A61K 47/36 B29C 33/424 B29C 39/003 B29C 39/025 B29C 39/10 B29C 43/003 B29C 43/021 B29C 43/20 A61M 2037/0023 A61M 2037/0046 A61M 2037/0053 B29C 2043/026 B29K 2105/0035 B29K 2883/00 B29L 2031/7544 B29L 2031/756
Filing Date
2025-05-08
Application No.
19202874
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Medical Devices (A61M)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Medical Devices (A61M) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.